HIF‐1α expression is frequently increased in solid cancers, including nonsmall cell lung carcinoma (NSCLC), breast carcinoma, and colorectal carcinoma, and the prognosis of patients with HIF‐1α overexpression is very poor.2, 8, 9. Here, HIF1A is linked to non-small cell lung carcinoma.